View Older Stories View More Recent Stories
-
SAGE Therapeutics (SAGE) Announces Strategic Reorganization to Prioritize ZURZUVAE Commercialization and Focus its Development Portfolio
-
Sage Therapeutics Announces Strategic Reorganization to Prioritize ZURZUVAE® Commercialization and Focus its Development Portfolio
-
Meta lays off employees at WhatsApp and Instagram, the Verge reports
-
Airbus says assessing financial impact of job cuts
-
EY survey reveals upcoming US presidential election will have notable impact on technology sector
-
ARC Awards $2 Million to the Jewish Healthcare Foundation to Build, Train, and Support Frontline Workforce in Nursing Homes in Pennsylvania
-
Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024
-
Airbus to cut up to 2,500 jobs in defence and space
-
Exclusive-Ryanair to cut traffic estimate for next year due to plane delivery delays
-
Analysis-Chinese finance professionals switch careers as industry crackdown dims prospects
-
Paramount assures bonus payouts for co-CEOs even if they exit roles
-
Boeing files for $25 billion shelf ahead of possible securities, share sale
-
Hundreds of Boeing workers rally in Seattle as strike enters second month
-
Boeing (BA) to lay off thousands of employees next month as part of announced job cuts - Reuters
-
Boeing to issue layoff notices to thousands next month, union and source say
-
Boeing prepares layoff notices for thousands of workers as turmoil deepens
-
China-Europe rivalry heats up at Paris car show as EV tariffs loom
-
Futures muted, earnings this week, Boeing job cuts - what's moving markets
-
Boeing falls after 10% layoff, $5bn charge
-
Toast Inc. (TOST) PT Raised to $30 at Baird
-
Stellantis CEO Tavares defends record in Paris over US crisis
-
Boeing to cut 17,000 jobs, delay first 777X jet as strike hits finances
-
CVS to exit core infusions services business, job cuts possible
-
Berlin says Sweden's Northvolt committed to project in Germany
-
Turnstone Biologics Corp (TSBX) Announces Strategic Restructuring
-
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
-
Exclusive-Northvolt in talks for about 200 million euros in funding, sources say
-
ByteDance's TikTok cuts hundreds of jobs in shift towards AI content moderation
-
Dow declares quarterly dividend of 70 cents per share
-
Full Circle Lithium's FCL-X™ Lithium-ion Battery Fire Extinguisher Now Available at AMAZON
-
VOXX International Corporation Reports its Fiscal 2025 Second Quarter Financial Results
-
Battery maker Northvolt says it will be able to pay its upcoming taxes
-
Quebec Real Estate Market: A Very Active Third Quarter Boosted by Lower Interest Rates and the Return of Buyer Confidence
-
Tesla to give permanent jobs to 500 temporary staff at German gigafactory
-
University of South Carolina unveils inaugural AI Index results
-
US consumer prices rise on food; Hurricane Helene muddies labor market picture
-
Shift to EV-only future would spell job losses, Toyota chairman warns
-
Lower Airbus deliveries put focus on 'challenging' target
-
Battery maker Northvolt says head of main plant to step down
-
AB: Materiality Check: The Next Stage of ESG and Responsible Investing
-
Piedmont Lithium (PLL) Reports Ewoyaa Lithium Project Received Mine Operating Permit
-
Ewoyaa Lithium Project Receives Mine Operating Permit
-
Clearside Biomedical (CLSD) Reports Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX
-
Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes
-
US dollar rises to two-month highs ahead of CPI
-
Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors
-
September Hiring Data Reveals Steep Declines for Small Businesses
-
China is oversupplying lithium to eliminate rivals, US official says
-
Northvolt subsidiary files for bankruptcy after project pulled
-
58% of Legal Departments Expect GenAI to Reduce Reliance on Outside Counsel and 25% Already Report Cost Savings, New ACC and Everlaw Survey Reveals
